AOR STRONTIUM SUPPORT II 341mg 120vcaps
Supports Bone Mineral Density
Clinically effective dose; Promotes healthy bone growth and mineralization; First strontium citrate supplement in the world.
In 2002, AOR introduced the world’s first supplemental strontium citrate for those with osteoporosis, osteopenia, post-menopausal women and those at an increased risk of bone fractures. AOR’s Strontium Support II comes in two sizes and provides an effective dose of this bone health powerhouse in a convenient one to two capsule-a-day formula.
Strontium is a trace mineral which concentrates in the skeletal system, where it supports the function of osteoblasts (the cells which form new bone) while reducing the differentiation and activity of osteoclasts (the cells which resorb old bone). Strontium Support II helps support bone mineral density.
Bone health; Osteoporosis; Osteopenia; Increases bone density; Reduces risk of fractures.
|Each capsule contains:
|Strontium (from strontium citrate)
Non-medical Ingredients: Capsule (hypromellose, glycerin and purified water), sodium stearyl fumarate.
Purity: AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Suggested Dose: Take one or two capsules daily on an empty stomach, at least two hours before or after consuming food, calcium or milk since these can significantly reduce strontium absorption if taken together. Ensure an adequate daily intake of calcium and vitamin D.
Cautions: Do not use if you are pregnant or breastfeeding, if you have or are at high risk for blood clots (e.g. if you are temporarily or permanently immobilized, over the age of 80, taking birth control pills, etc.), heart diseases and/or circulatory problems (e.g. Venous Thromboembolism (VTE), heart attack, peripheral arterial disease, stroke, high blood pressure, hyperlipidemia, diabetes, etc.), or have kidney disease. May cause temporary transient increases in levels of creatine kinase that are unassociated with any disorder. Discontinue use and consult a health care practitioner in case of rash or hypersensitivity, as this may be a sign of a serious allergic reaction (DRESS or Stevens-Johnson syndrome). Consult a health care practitioner for use beyond 6 months.